Sodium chloride solution 3,5%: Patients will receive 150 mL HSS 3,5% intravenous twice daily for 3 days after heart transplantation.
Sodium chloride solution 0,9%: Patients will receive 150 mL NS 0,9% intravenous twice daily for 3 days after heart transplantation.
Study summary
The goal of this study is to evaluate if hypertonic saline solution can prevent or attenuate acute kidney injury after heart transplantation in the early postoperative phase.
Eligibility
Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
Accepted
Inclusion Criteria:
* Hospitalized patients submitted to orthotopic heart transplantation (HT)
Exclusion Criteria:
* Requirement of renal replacement therapy at the time of HT
* Requirement of extracorporeal membrane oxygenation (ECMO) before or immediately after HT
* Severe peri-operative mechanical complications
* Double transplant (e.g. heart-kidney or heart-lung)
* Hypernatremia (Na ≥ 145)
* Severe hyponatremia (Na ≤ 120)
Primary outcome measure(s)
Prevention of acute kidney injury — Days 3 -7 post-transplantation Demonstrate a peak value of creatinine 30% lower in the active arm
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.